We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




World’s First Miniaturized Robotic-Assisted Surgery System Allows Operating Room to Be Set Up in Minutes

By HospiMedica International staff writers
Posted on 20 Sep 2023

Most routine and high-volume procedures are usually carried out in outpatient and day surgery centers, where there is often no availability of robotic-assisted surgery (RAS). More...

Now, a miniaturized version of an RAS system, or miniRAS, with a small form factor aims to change this. This miniaturized system can fit into a regular surgical tray and is aimed at making RAS accessible to a large number of patients who currently do not have access to the technology.

Virtual Incision Corporation (Lincoln, NE, USA), which is focused on advancing patient access to RAS, is the developer of the world’s first miniaturized RAS system named MIRA. This device has a compact design that enables the advantages of RAS for abdominal surgeries without the logistical hassles associated with traditional robotic mainframes. Weighing around two pounds, MIRA features internal components that provide a high level of maneuverability within the body. It is adaptable to any operating room setting, eliminating the need for a dedicated mainframe room. MIRA’s design, which requires neither draping nor docking, makes it quick to set up and move from one case to another. It can function independently or supplement existing mainframe systems.

Going forward, Virtual Incision will lay the foundation for performing telesurgery in outer space. A modified MIRA will be placed in the International Space Station to carry out simulated surgeries from a microwave-sized locker, thanks to its small form factor and RAS capabilities. The company is also working on an even smaller version of the robot for more general surgical uses, with human clinical trials planned for next year. Recently, Virtual Incision concluded an Investigational Device Exemption (IDE) study for using MIRA in bowel resections. Currently, its De Novo application is undergoing substantive review by the U.S. Food and Drug Administration (FDA). If approved, a limited rollout of MIRA at select locations in the U.S. is planned.

Related Links:
Virtual Incision Corporation 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Leg Wraps
Leg Wraps
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new AI-based method can predict treatment outcomes from health record data (Photo courtesy of 123RF)

AI Tool Accurately Sorts Cancer Patients by Likely Outcomes

Pharmaceutical companies and healthcare providers often face the challenge of determining which patients will respond most effectively to a given drug. A new artificial intelligence (AI)-based method has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.